Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy
MWN-AI** Summary
Cosmos Health Inc. (NASDAQ:COSM), a global healthcare group based in Chicago, has secured a financing facility of up to $300 million through a securities purchase agreement with a U.S.-based institutional investor. This funding will support Cosmos Health's strategic launch of a digital asset treasury reserve, specifically focused on accumulating Ethereum (ETH). The financing is comprised of senior secured convertible promissory notes, contingent upon meeting specific conditions.
The initiative is aimed at enhancing long-term shareholder value by increasing the ETH-per-share, with plans for the ETH assets to be stored and staked via BitGo Trust Company, Inc. This treasury strategy aligns with Cosmos Health's broader digital transformation efforts and potential explorations of blockchain technologies for applications such as supply chain traceability and wellness incentive programs.
CEO Greg Siokas emphasized that this financing represents a significant milestone for the company, providing shareholders with direct exposure to a highly adopted digital asset while simultaneously providing growth capital for various strategic initiatives—ranging from product development and R&D innovations to enhancing commercial operations and establishing U.S. manufacturing.
Under the terms, at least 72.5% of net proceeds from each tranche will be allocated toward building the ETH treasury, ensuring that the financing primarily supports the upcoming digital asset strategy. Curvature Securities, LLC acted as the sole placement agent in this arrangement.
This move to enter the digital asset space signals Cosmos Health's commitment to innovation and long-term value creation, positioning the company favorably for future growth across its diversified healthcare business. For additional details, stakeholders can refer to Cosmos Health’s Current Report filed with the SEC.
MWN-AI** Analysis
Cosmos Health Inc. (NASDAQ:COSM) has recently secured up to a $300 million financing facility to initiate its Ethereum treasury strategy, a move that underscores its commitment to incorporating digital assets into its operational framework. This strategy is poised to offer significant advantages for shareholders by potentially increasing the company’s ETH-per-share while simultaneously diversifying its asset portfolio.
The decision to allocate a substantial portion of the proceeds—at least 72.5%—towards building an ETH treasury reserve, combined with the plan to utilize trusted custodial services from BitGo, signals a robust approach to capital management. Investors should consider the implications of this shift; as Cosmos Health diversifies into digital assets, this could provide a hedge against traditional market volatility and enhance overall shareholder value.
CEO Greg Siokas emphasized that the financing reflects a strategic milestone, aimed at fostering innovation and supporting product development and R&D initiatives. The integration of blockchain technology can improve supply chain traceability and create new avenues for consumer engagement, which may yield long-term benefits that align with industry trends towards digital transformation.
While the entry into digital assets can be seen as opportunistic, it’s essential to balance this optimism with caution. The volatility of the cryptocurrency market poses inherent risks, and Cosmos Health’s ability to effectively manage these assets is crucial. Additionally, investors should remain vigilant about the company’s broader operational goals, especially as it ventures into U.S. manufacturing and explores yield-generating strategies.
Overall, the financing represents a noteworthy strategic shift for Cosmos Health. Investors should keep a close eye on how these initiatives evolve and their potential impact on both near-term performance and long-term value creation. As always, a thorough analysis of risk factors highlighted in SEC filings is advisable before making investment decisions.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
CHICAGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, announced today that it has entered into a securities purchase agreement with a U.S.-based institutional investor for the issuance of up to $300 million in senior secured convertible promissory notes (the “Facility”), subject to the satisfaction or waiver of certain conditions, to support the launch of its Ethereum (ETH) digital asset treasury reserve strategy.
Key Highlights:
- Strategic accumulation of ETH to enhance long-term shareholder value through increasing ETH-per-share
- ETH assets will be custodied and staked through institutional infrastructure provided by BitGo Trust Company, Inc. (“BitGo”)
- Treasury initiative complements Cosmos Health’s ongoing digital transformation and e-commerce efforts, with potential to explore blockchain use cases in supply chain traceability, wellness incentive programs, and global consumer engagement
- The Company plans to explore additional yield-generating strategies to optimize cash flow and utility from ETH holdings
Greg Siokas, CEO of Cosmos Health, stated: “This financing marks a strategic milestone for Cosmos Health, offering shareholders direct exposure to ETH, currently one of the most widely adopted digital assets in the world. It also provides access to growth capital to support a range of strategic initiatives, including accelerated product development, advanced R&D innovation, enhanced commercial initiatives, and our planned entry into U.S. manufacturing.”
“Our entry into the digital asset space is not a short-term pivot, but part of a broader commitment to innovation,” Greg Siokas continued. “We are confident that the size and flexibility of this facility should position us to deliver long-term, sustainable value for our shareholders.”
Under the terms of the Facility, Cosmos Health is required to allocate at least 72.5% of the net proceeds from each tranche closing toward building its digital asset treasury reserve, with the remainder to be used for working capital and various growth initiatives.
Curvature Securities, LLC acted as the sole placement agent in connection with the Facility.
The foregoing description is a summary only and does not purport to be complete. For further information, please refer to Cosmos Health’s Current Report on Form 8-K, which will be available on the Securities and Exchange Commission’s website at www.sec.gov .
About Cosmos Health Inc.
Cosmos Health Inc. (Nasdaq:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK. More information is available at www.cosmoshealthinc.com , www.skypremiumlife.com , www.cana.gr , www.zipdoctor.co , www.cloudscreen.gr , as well as LinkedIn and X .
Forward-Looking Statements
With the exception of the historical information contained in this news release, the matters described herein, may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements preceded by, followed by, or that otherwise, include the words "believes," "expects," "anticipates," "intends," "projects," "estimates," "plans" and similar expressions or future or conditional verbs such as "will," "should," "would," "may" and "could", are generally forward-looking in nature and not historical facts, although not all forward-looking statements include the foregoing. Such forward-looking statements include, but are not limited to, the Company’s expectation that accumulation of ETH will enhance long-term shareholder value through increasing ETH-per-share, the Company’s plans to explore additional yield-generating strategies to optimize cash flow and utility from ETH holdings, that the Facility will provide access to growth capital to support a range of strategic initiatives, including accelerated product development, advanced R&D innovation, enhanced commercial initiatives, and the Company’s planned entry into U.S. manufacturing and the anticipated use of proceeds. These statements, involve unknown risks and uncertainties that may individually or materially impact the matters discussed, herein for a variety of reasons that are outside the control of the Company, including, but not limited to, the Company's ability to raise sufficient financing to implement its business plan, and the Company's ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward-looking statements, as actual results could differ materially from those described in the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the Company's filings with the SEC, which are available at the SEC's website ( www.sec.gov ). The Company disclaims any intention or obligation to update, or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations Contact:
BDG Communications
cosm@bdgcommunications.com
Disclaimer
This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a COSM financial position. COSM financial position and all other information regarding the featured Company should be verified directly with COSM. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in COSM is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of COSM shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Compensation: Market Wire News and its affiliates has received six thousand dollars for Market Wire News advertising services from Relqo Media LLC for Brand Awareness Distribution, Corporate Communications, News, Press Release Enhancement and Social Media Solutions starting 2026-05-31 and ending 2026-06-05 provided by Market Wire News. To date, we have received a total of six thousand dollars. Please read our full disclaimer for compensation and more detailed information.
FAQ**
How will Cosmos Holdings Inc. COSM manage the risks associated with their significant investment in Ethereum (ETH) as part of their treasury reserve strategy, particularly in the face of market volatility?
What specific yield-generating strategies does Cosmos Holdings Inc. COSM plan to explore to optimize cash flow from their ETH holdings and how will these initiatives be integrated into their existing operations?
Can Cosmos Holdings Inc. COSM provide more details on how the strategic accumulation of ETH is expected to enhance long-term shareholder value through increasing ETH-per-share?
What are the anticipated impacts on product development and innovation at Cosmos Holdings Inc. COSM as they enter the U.S. manufacturing space while simultaneously launching their digital asset treasury reserve strategy?
**MWN-AI FAQ is based on asking OpenAI questions about Cosmos Health Inc. (NASDAQ: COSM).
NASDAQ: COSM
COSM Trading
2.67% G/L:
$0.2572 Last:
2,524,082 Volume:
$0.2525 Open:
